Atlas Trials

Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome

Clinical trial NCT00403689 · COMPLETED

Trial details

NCT number
NCT00403689
Sponsor
German Institute of Human Nutrition
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Overweight
Start date
2006-11-01
Primary completion
2008-03-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.